Name | Number of supported studies | Average coverage | |
---|---|---|---|
respiratory goblet cell | 4 studies | 35% ± 8% | |
club cell | 3 studies | 31% ± 5% |
Insufficient scRNA-seq data for expression of UGT2A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 92% | 143.48 | 209 / 226 | 1% | 0.04 | 6 / 406 |
kidney | 82% | 112.46 | 73 / 89 | 0% | 0.00 | 2 / 901 |
skin | 48% | 22.36 | 869 / 1809 | 0% | 0.01 | 1 / 472 |
lung | 8% | 4.21 | 46 / 578 | 4% | 0.58 | 50 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.50 | 3 / 45 |
uterus | 4% | 0.47 | 6 / 170 | 2% | 0.17 | 10 / 459 |
peripheral blood | 4% | 1.07 | 36 / 929 | 0% | 0 | 0 / 0 |
spleen | 2% | 0.31 | 6 / 241 | 0% | 0 | 0 / 0 |
prostate | 2% | 0.21 | 5 / 245 | 0% | 0 | 0 / 502 |
breast | 1% | 0.10 | 3 / 459 | 0% | 0.01 | 3 / 1118 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.20 | 4 / 504 |
adrenal gland | 1% | 0.42 | 2 / 258 | 0% | 0 | 0 / 230 |
esophagus | 0% | 0.04 | 3 / 1445 | 1% | 0.01 | 1 / 183 |
adipose | 1% | 0.13 | 8 / 1204 | 0% | 0 | 0 / 0 |
stomach | 0% | 0.21 | 1 / 359 | 0% | 0.02 | 1 / 286 |
blood vessel | 1% | 0.07 | 7 / 1335 | 0% | 0 | 0 / 0 |
thymus | 0% | 0.06 | 2 / 653 | 0% | 0.07 | 1 / 605 |
heart | 0% | 0.04 | 4 / 861 | 0% | 0 | 0 / 0 |
intestine | 0% | 0.03 | 2 / 966 | 0% | 0.00 | 1 / 527 |
pancreas | 0% | 0.03 | 1 / 328 | 0% | 0 | 0 / 178 |
brain | 0% | 0.02 | 6 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007608 | Biological process | sensory perception of smell |
GO_0008206 | Biological process | bile acid metabolic process |
GO_0052695 | Biological process | cellular glucuronidation |
GO_0007606 | Biological process | sensory perception of chemical stimulus |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0015020 | Molecular function | glucuronosyltransferase activity |
Gene name | UGT2A1 |
Protein name | UDP-glucuronosyltransferase 2A1 (UDPGT 2A1) (UGT2A1) (EC 2.4.1.17) UDP-glucuronosyltransferase 2A1 UDP-glucuronosyltransferase (EC 2.4.1.17) UDP glucuronosyltransferase family 2 member A1 complex locus |
Synonyms | |
Description | FUNCTION: UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile . Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds . Catalyzes the glucuronidation of endogenous steroid hormones such as androgens (testosterone and epitestosterone) and estrogens (estradiol and epiestriol) . Contributes to bile acid (BA) detoxification by catalyzing the glucuronidation of BA substrates, which are natural detergents for dietary lipids absorption . Shows a high affinity to aliphatic odorants such as citronellol as well as olfactory tissue specificity, and therefore may be involved in olfaction . Shows a potential role in detoxification of toxic waste compounds in the amniotic fluid before birth, and air-born chemical after birth . . |
Accessions | A0A140T9Z0 D6RFW5 ENST00000512704.5 ENST00000514019 ENST00000286604.9 [P0DTE4-5] ENST00000514019.1 [P0DTE4-4] ENST00000505512.1 ENST00000503640.5 [P0DTE4-1] P0DTE4 D6RHF3 |